Ono Pharmaceutical Acquires Deciphera Pharmaceuticals
June 12, 2024
Ono Pharmaceutical Co., Ltd. completed its previously announced tender offer to acquire all outstanding shares of Deciphera Pharmaceuticals Inc. for $25.60 per share, totaling approximately $2.4 billion. Following the tender offer, a wholly-owned subsidiary merged with and into Deciphera, with Deciphera surviving as a wholly owned subsidiary of Ono.
- Buyers
- Ono Pharmaceutical Co., Ltd., Topaz Merger Sub Inc.
- Targets
- Deciphera Pharmaceuticals Inc.
- Industry
- Pharmaceuticals
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.